# Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation

> **NCT03247413** · PHASE4 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 63 (actual)

## Conditions studied

- Neuritis
- Radiofrequency Ablation

## Interventions

- **DRUG:** Dexamethasone 4 mg/ml
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03247413
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-01
- **Primary completion:** 2022-10-14
- **Final completion:** 2022-10-14
- **Target enrollment:** 63 (ACTUAL)
- **Why stopped:** Study has been halted prematurely
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03247413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03247413, "Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03247413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*